je.st
news
Tag: astrazeneca
AstraZeneca bets on "genetic scissors" for range of new drugs
2015-01-29 12:24:27| Biotech - Topix.net
AstraZeneca said on Thursday it had struck four research agreements in the hot area of genome editing as it bets on a new "genetic scissors" technology to deliver better and more precise drugs for a range of diseases. The academic and commercial tie-ups will allow British-based AstraZeneca to use so-called CRISPR technology across its entire drug discovery platform in areas such as oncology, cardiovascular, respiratory and immune system medicine.
Tags: range
drugs
genetic
bets
AstraZeneca CEO says new Pfizer bid unlikely - Swedish daily DI
2014-12-20 20:01:28| Biotech - Topix.net
U.S. Pfizer is unlikely to come back with a fresh bid for AstraZeneca , the Anglo-Swedish pharmaceuticals group's top executive was quoted as saying by Swedish business daily Dagens Industri on Saturday. AstraZeneca saw off a $118 billion approach from Pfizer in May and British takeover rules now allow Pfizer to renew its pursuit.
AstraZeneca cancer drug, companion test approved
2014-12-19 21:03:21| Biotech - Topix.net
U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from British drugmaker AstraZeneca PLC . The drug is for women whose ovarian cancer is associated with certain defective genes and whose cancer persists after multiple treatments.
Tags: test
approved
drug
cancer
AstraZeneca Announces Plans To Expand Its Frederick, Maryland Biologics Manufacturing Center
2014-12-03 07:04:35| drugdiscoveryonline News Articles
AstraZeneca recently announced plans to expand its biologics manufacturing center in Frederick, Md. The more than $200M project will increase production capacity at the facility to support AstraZeneca’s maturing pipeline, and will help position the company to keep pace with a growing demand for the development and use of biologics, which currently represent nearly 50% of AstraZeneca’s overall pipeline
Tags: center
plans
expand
manufacturing
Amgen And AstraZeneca Announce Positive Results From Third And Final...
2014-11-26 10:28:14| Biotech - Topix.net
Amgen and AstraZeneca today announced that AMAGINE-2TM, a pivotal, multi-arm Phase 3 trial evaluating two doses of brodalumab in more than 1,800 patients with moderate-to-severe plaque psoriasis, met its primary endpoints when compared with both StelaraA and placebo at week 12. Brodalumab 210 mg given every two weeks and the brodalumab weight-based analysis group were each shown to be superior to Stelara on the primary endpoint of achieving total clearance of skin disease, as measured by the Psoriasis Area Severity Index .
Tags: results
final
third
positive
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] next »